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ABSTRACT 
 
Dietary agents are important factors in regulating the development of diseases such as 
cancer. Several in vitro and animal studies have provided evidence that dietary 
intervention can prevent cancer development. In addition, studies show that many 
cancer patients already use natural products or supplements so it is valuable to explore 
how these agents might benefit health. Black raspberries are a good example of a 
dietary super-food. Despite data showing that this whole food or metabolites within it 
can inhibit cancer cell growth in vitro and in animal models, we do not know the 
mechanisms by which they act. We studied the effect of lyophilized black raspberry 
extract (BRB-E) and black raspberry metabolites, cyanadin-3-rutinoside (C3R) and 
quercetin-3-rutinoside (Q3R), on T lymphocyte function and Myeloid Derived 
Suppressor Cell (MDSC) expansion in vitro. T lymphocytes are important for the ability 
to detect and eliminate cancer.  In contrast, MDSCs can suppress the immune system 
and prevent cytotoxic cells from recognizing and eliminating tumor cells. Pro-
inflammatory cytokines and proteins such as phosphorylated STAT3 drive MDSC 
expansion. We hypothesized that lyophilized black raspberries or bioactive compounds 
derived from them would reduce the inflammatory changes that promote tumor 
development or metastasis. We observed that BRB-E and its metabolites C3R and Q3R 
suppressed T cell proliferation. We also determined that BRB-E enhanced T cell 
migration via CXCR3 receptor upregulation. Furthermore, BRB-E and its metabolites 
inhibited in vitro MDSC differentiation and STAT3 phosphorylation. These data suggest 
mechanisms by which black raspberry can be immunomodulatory and can be applied to 
regulating diseases such as cancer.   
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INTRODUCTION 
 
Dietary intervention is an expanding field, and may play a role in cancer prevention and 
therapy. It offers a natural means to physiologically counteract diseases such as cancer. 
Fruit and vegetable consumption has long been suggested as a means for disease 
prevention.1 Research has demonstrated that black raspberries can act at the level of 
the tumor cell to inhibit growth.2 However, few studies have addressed their effects on 
immunity. Black raspberries are good candidates for investigation due to their large 
content of anti-cancer compounds such as vitamin C and E, anthocyanins, flavonoids, 
selenium, dietary fiber, and plant sterols.3 Several preclinical in vivo and in vitro models 
have demonstrated the effectiveness of whole lyophilized black raspberry.4 We also 
investigated two specific metabolites produced by the body following black raspberry 
consumption in humans.  Cyanidin-3-rutinoside (C3R), the main anthocyanin 
component of black raspberry, has been found to inhibit migration and invasion of 
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cancer cells, including lung carcinoma cells.5 Quercetin, another metabolite, is a major 
flavonoid and has been shown to act as a strong antioxidant. 6 We hypothesized that an 
ethanol based black raspberry extract would modulate T cell function and myeloid cell 
differentiation. 
 
T cells are important for immune function and cancer prevention as they may eliminate 
virally infected or cancerous cells in an antigen-specific manner.  However, their actions 
are quite complicated as certain subsets of T cells may also serve to limit immune 
responses.  Three major types of T lymphocytes in the immune system are T helper 
cells (CD4+), cytotoxic T cells (CD8+) and T regulatory cells (CD4+CD25+FoxP3+). T 
cell activation requires 2 signals, one at the CD3 receptor and another at the CD28 
receptor. The CD3 receptor binds to an antigen molecule presented by an antigen 
presenting cell (APC).  Costimulation at the CD28 receptor by an APC protein is the 
second signal needed to activate T cells. Activated T cells can proliferate and migrate to 
the periphery. In a normal, healthy immune system, CD4+ T cells are activated by APC 
via presenting peptides on major histocompatibility class I (MHC I) molecules to help 
other immune cells in their responses. CD8+ T cells are also activated by APC via 
peptides presented on MHC II molecules. Once they see antigen, these CD8+ cytotoxic 
T cells can lyse target cells via mechanisms such as perforin and granzyme B secretion. 
In contrast, T regulatory cells are immunosuppressive. They function in the body to 
regulate the immune response by preventing too strong of an inflammatory response, 
as well as preventing autoimmunity. In the setting of cancer, T regulatory cells can be 
immunosuppressive and act to inhibit the immune system from fighting tumor cells.7 The 
ability of T cells to migrate is also important for normal immune function.  This process 
is regulated by chemokines, which allow immune cells to move to sites of tissue 
damage, infection, or cancer.8  Monokine induced by gamma (MIG) is a chemokine that 
binds to the CXCR3 T cell receptor. The CXCR3/MIG system is an example of an 
inflammatory chemokine system allowing for activated T cell to migrate.9  
 
The second subset of cells we focused on were myeloid derived suppressor cells 
(MDSCs), which are immunosuppressive and originate from myeloid cells in the bone 
marrow. MDSCs are characterized by their cell surface makers and in humans have the 
phenotype CD33+CD11b+HLADR-CD15+. During inflammatory events such as infection 
or cancer, MDSCs migrate from bone marrow to peripheral tissues. In a healthy immune 
system, MDSCs function to protect against too extreme of an immune response. 
However, elevated MDSC populations are found at sites of inflammation.  In peripheral 
blood samples of cancer patients, up to a 10-fold increased in MDSC numbers can be 
found.10 MDSCs play an important role in promoting carcinogenesis by inhibiting natural 
killer cells (NK cell) and cytotoxic T cells (CTL) via iNOS and arginase-I (ArgI) enzymes. 
MDSCs can also promote another immunosuppressive subset of cells called regulatory 
T cells (T reg) through the proteins such as transforming growth factor beta	  (TGF-β).11,12  
In a host with cancer, cells from the tumor, stroma, and immune system can secrete 
cytokines such as interleukin-6 (IL-6) and granulocyte macrophage-colony stimulating 
factor (GM-CSF) that promote differentiation MDSCs (Figure 1). IL-6 is a pro-
inflammatory cytokine that activates Janus kinases (JAKs), which in turn phosphorylate 
and activate STAT3 (signal transducer and activator of transcription factor 3). 
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Phosphorylated STAT3 (pSTAT3) can move to the nucleus and bind to specific portions 
of DNA to regulate the transcription of genes involved in cell growth, movement, and 
apoptosis.13 STAT3 is noted to be overactive in various forms of cancer, which is 
believed to contribute to the growth and division of cancer cells.14 The IL-6/STAT3 
pathway is also thought to promote immune suppression as it is a key pathway in 
MDSC generation.  
 
Our data suggests that an ethanol based black raspberry extract and its metabolites, 
C3R and Q3R act to regulate lymphocyte function and myeloid cell differentiation. 
Understanding the mechanisms by which black raspberries can affect the immune 
system is important as it has the potential to be used as a novel therapy for 
inflammatory diseases such as cancer.  
 
 
 
 
 
 
 
 
 
 
 
Figure 1. 
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MATERIALS AND METHODS 
 
Reagents 
 
Lyophilized black raspberry extract (BRB-E) was obtained from the laboratory of Dr. 
Christopher Weghorst.4 Black raspberries were freeze-dried and the lyophilized black 
raspberry powder was extracted with ethanol to yield a residue. Next, this residue was 
resuspended in dimethyl sulfoxide (DMSO). Aliquots were stored at – 80°C. Cyanidin-3-
rutinoside (C3R) and quercetin-3-rutinoside (Q3R) were purchased from Indofine and 
Sigma Aldrich, respectively.  Recombinant human interleukin-6 (IL-6) and granulocyte 
macrophage colony stimulating factor (GM-CSF) were purchased from Peprotech 
(Rocky Hill, NJ).   
 
Peripheral Blood Mononuclear Cell (PBMC) and T cell Isolation  
 
Peripheral Blood Mononuclear Cells (PBMCs) were separated from healthy donor 
source leukocytes (American Red Cross, Columbus, OH) using density gradient 
centrifugation with Ficoll-Pacque (Amersham Pharmacia Biotech, Uppsala, 
Sweden) as previously described.15,16 T cells were negatively selected using 
Rosette Sep reagents, as described by the manufacturer (Stem Cell Technologies, 
Vancouver, BC). Cells were cultured in RPMI 1640 (Gibco) supplemented with 
10% fetal bovine serum and antibiotics. 
 
 
CFSE T Cell Proliferation Assay 
 
T cells were isolated from source leukocytes from donor blood using negative selection 
using Rosette Sep (Stem Cell Technologies, Inc., Vancouver, British Columbia, 
Canada). The isolated T cells were labeled with 1 µM CFSE, an intracellular fluorescent 
label (Invitrogen, Grand Island, NY). The labeled T cells were cultured for 3 days with 
CD3/CD28 beads (Invitrogen, Grand Island, NY) and DMSO (control), BRB-E (200 
µg/mL), C3R (200 µM), or Q3R (200 µM). The cells were collected, stained, and 
analyzed for CD4+ or CD8+ T cells using flow cytometry on a FACS Calibur (BD 
Biosciences). The percent of T cell proliferation was determined by the dilution of CFSE. 
(Figure 2.) 
 
 
 
Figure 2. 
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T cell migration assay 
 
T cells were isolated from healthy donor leukocytes as described above and activated 
with CD3 and CD28 beads for 7 days with or without BRB-E at 200 ug/mL. After 7 days, 
one million activated T cells were loaded into the top chamber of transwell inserts (5.0 
µM pore size, Costar, Inc.).  Media containing monokine-induced by gamma (MIG) was 
placed in the bottom well as a chemoattractant and positive control (R&D Systems, 
Inc.). RPMI media alone was used as a negative control. After the plates were 
incubated for 3 hours at 37°C, the percentage of T cells in the bottom chamber was 
calculated using trypan blue exclusion and/or flow cytometry to verify T cell phenotype. 
Flow cytometry was used to determine the percent of T cells expressing CXCR3 
receptors and the mean fluorescent intensity of CXCR3. (Figure 3.) 
 
 
Figure 3. 
 
 
MDSC generation in vitro 
 
MDSCs were generated in vitro by adding IL-6 and GM-CSF to isolated PBMCs 
in media at 10ng/mL concentration each, as previously described.15,16 Cells were 
treated BRB-E, C3R or Q3R at several concentrations. Cells were cultured at 
37°C for 7 days with media and cytokine changed every 2-3 days. After a period 
of 7 days, cells were harvested, stained, and analyzed via flow cytometry.  Cells 
were stained using the following mouse anti-human antibodies for MDSC surface 
makers: CD11b-PE, CD33-APC, CD15-FITC, HLA-DR- PE-Cy7. The isotype control 
was stained with the respective mouse antibodies. Following staining, cells were 
incubated for 30 minutes on ice. Cells were washed with FACS buffer and fixed in PBS 
with 1% formalin. Cells were run on a FACS calibur or LSRII flow cytometer (BD 
Biosciences, San Jose, CA). The data was analyzed using FlowJo software. (Figure 4) 
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Figure 4.  
 
 
T cell suppression assay by in vitro generated MDSCs 
 
In vitro generated MDSCs were tested for functionality using a T cell suppression 
assay. MDSCs were isolated using CD33+ magnetic bead selection and co-
cultured with CFSE labeled isolated T cells for 3 days in the presence of 
CD3/CD28. T cell proliferation was assayed using flow cytometry. (Figure 5) 
 
 
 
Figure 5.  
 
 
Immunoblot analysis 
 
PBMCs were cultured with black raspberry extract or its metabolites. Lysates were 
prepared in Laemelli buffer and assayed for protein expression as previously described 
via immunoblot analysis with antibodies (Ab) to STAT3, pSTAT3, and beta actin 
(Sigma).17 After incubation with horseradish-peroxidase-conjugated secondary Ab, 
protein expression was detected using the SuperSignal West Pico Chemiluminescent 
Substrate (Thermo Fisher Scientific, Rockford IL). (Figure 6) 
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RESULTS  
 
 
Immune cell viability is not affected by ethanol extract from black raspberries 
 
PBMCs from several healthy donors were cultured for 3 days with the ethanol based 
black raspberry extract (BRB-E). Cell survival was analyzed by annexin V/PI staining 
and flow cytometric analysis. Concentrations of BRB-E ranging from 0-400 μg/ml 
showed no significant effects on cell viability. (Figure 7)  
 
 
Figure 7. 
 
 
T cell proliferation is inhibited by black raspberry extract and its metabolites 
 
CD3+ T cells were isolated from PBMCs from donor blood from the Red Cross via 
negative selection as described above. (8A) The T cells were fluorescently labeled with 
CFSE to assess proliferation. The T cells were also stimulated with beads that activated 
CD3 and CD28 surface markers or unstimulated (negative control). When BRB-E was 
added to the T cell cultures (8B) CD4+ T lymphocyte and (8C) CD8+ T lymphocyte 
proliferation was inhibited. The effects of the BRB-E were noted to behave in a dose 
dependent manner.   
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Figure 8A.  
 
 
 
Figure 8B.  
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Figure 8C 
 
 
 
T cell migration is enhanced by black raspberry extract via chemokine receptor 
upregulation  
 
T cells activated by CD3/CD28 beads were placed in a transwell plate containing MIG 
(monokine induced by gamma). (9A) A significant increase in T cell chemotaxis 
(p=0.01) was observed in T cells incubated with BRB-E. Using flow cytometry, CXCR3 
(the receptor for MIG) was found to be upregulated in both CD4+ and CD8+ T cells. An 
increase in the (9B) percentage of cells expressing CXCR3 and the (9C) mean 
fluorescent intensity of CXCR3 was observed.  
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Figure 9B. 
 
 
 
 
Figure 9C.  
 
 
 
Black raspberry extract inhibits MDSC differentiation in vitro 
 
Donor blood from the Red Cross was used to isolate PBMCs using Ficoll-Paque as 
described above. PBMCs were stimulated with IL-6 and GM-CSF (10ng/mL each) for 7 
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were collected, stained and analyzed via flow cytometry. Cells were stained for an 
MDSC phenotype. (10A) Representative flow cytometric analysis of MDSC generation 
in vitro. When comparing unstimulated (top panel) versus stimulated (bottom panel) 
conditions, we see an increase in CD11b+, CD33+ MDSC cells. (10B) Addition of black 
raspberry extract was noted to consistently inhibit MDSC generation in vitro as 
compared to DMSO, the vehicle that was used as a control. (10C) These in vitro 
generated MDSCs were tested for functionality in that they were able to suppress 
autologous T cell proliferation.  
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Figure 10C.  
 
 
 
IL-6 induced STAT3 phosphorylation is reduced by black raspberry and its metabolites 
 
PBMCs from donor blood were isolated using methods described above. These cells 
were incubated with BRB-E, C3R, Q3R, or the DMSO control for 4 hours. After 
incubation, the cells were stimulated with IL-6 at 0, 1, or 5 ng/ml concentration for 20 
minutes. Next, lysates were made and analyzed via immunoblot. Pre-treatment of cells 
with BRB-E, C3R, or Q3R was shown to reduce expression of phosphorylated STAT3. 
Total STAT3 levels were not noted to change. Beta actin was used as a loading control. 
(Figure 11) 
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Figure 11.  
 
 
Metabolites of black raspberry also inhibit MDSC generation and T cell proliferation 
 
(12A) Isolated PBMCs, as described above, were cultured with DMSO, BRB-E, C3R, or 
Q3R and stimulated with IL-6/GM-CSF (10 ng/ml) for 7 days. The presence of black 
raspberry or its metabolites inhibited MDSC generation as compared to the DMSO 
control. (12B) Isolated T cells, as described above, were cultured with DMSO (control), 
BRB-E, C3R, or Q3R. Histograms represent flow cytomteric analysis of showing 
inhibition of CFSE diluted CD4+ T cells by black raspberry and its metabolites.  
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Figure 12B.  
 
 
 
 
DISCUSSION 
 
Our findings suggest that an ethanol based black raspberry extract and its metabolites, 
cyanidin-3-rutinoside and quercetin-3-rutinoside have an immunomodulatory effect on T 
lymphocyte function and MDSC generation. Black raspberries are a natural, food-based 
approach to inhibit carcinogenesis that is gaining interest based on data in vitro and in 
animal models.18,2 Prior studies have shown that black raspberry can inhibit proliferation 
and promote apoptosis in malignant cells.3 However few, if any, studies to date have 
explored how they might act on the immune system. Our current results are important 
because they present some of the immune mechanisms by which black raspberry can 
act. These mechanisms could then be directed towards regulating diseases involving 
chronic inflammation such as cancer, atherosclerosis, and autoimmune diseases.19 
Thus, this area of research has the potential to be used in a variety of applications.   
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We found that BRB-E had interesting effects on T lymphocytes in vitro. We saw a 
significant increase in T lymphocyte chemotaxis in the presence of BRB-E. We also saw 
an upregulation in the CXCR3 receptor expression in both CD4+ and CD8+ cells. 
Enhanced T cell migration could be beneficial in anti-cancer responses. However, this 
may also have the potential to aggravate the progression of the disease depending on 
the T cell subset. For example, if the ability of T regulatory cells to reach the tumor was 
enhanced, this could promote tumor progression.  Inhibition of T cell proliferation by 
BRB-E could also be beneficial or harmful depending on the environment.20 Thus, these 
observations need to be further studied to fully understand the significance of BRB-E.   
 
In addition to effects on T lymphocyte function, we also found that BRB-E modulates 
MDSC differentiation. Elevated MDSC are found at sites of inflammation and cancer. 
They act to suppress immune responses and can thus exacerbate the pathology of the 
disease.10 We also observed that the presence of BRB-E inhibited STAT3 
phosphorylation, an important transcription factor required for MDSC differentiation. 
This suggests a mechanism by which BRB-E inhibits MDSC differentiation.  
 
Furthermore, we investigated the bioactive metabolites within black raspberry as this 
could be important for future development of drugs that may modulate immune function. 
Both anthocyanin and quercetin compounds have been shown to have anti-cancer 
effects.5 We found that both cyanidin-3-rutinoside and quercetin-3-rutinoside had similar 
effects to BRB-E in modulating T cell function and MDSC generation. These specific 
compounds also have the potential to be isolated and used in therapy of diseases such 
as cancer.  
 
Black raspberry has the potential to be used as a beneficial dietary intervention but its 
effects require further investigation. Digestion, metabolism, and absorption of black 
raspberry may alter the bioactive compounds studied. In addition, genetic differences 
among individuals may affect its metabolism.  Metabolite processing may also vary in 
individuals depending on their oral and intestinal microbiota.21 The effects of black 
raspberry thus need to be further evaluated in vivo models and clinical trials to 
understand how it can be implemented to benefit patients. In conclusion, our results 
show that black raspberries and its metabolites can modulate immune function by 
influencing T cell function and MDSC generation. These findings have various potential 
applications such as dietary intervention or drug development in diseases such as 
cancer. 
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